| Title |
A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical–chemical risk factors of cardiovascular disease in a primary care setting
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, February 2001
|
| DOI | 10.1007/s002280000247 |
| Pubmed ID | |
| Authors |
G.E. Schuitemaker, G.A. van der Pol, C.P.M. Aretz, G.J. Dinant |
| Abstract |
Lipid-lowering drugs are extensively used in primary care to reduce the risk of cardiovascular disease (CVD). Apart from high total cholesterol (TC), several other clinical-chemical variables are associated with the risk of CVD. Magnesium-pyridoxal-5'-phosphate-glutamate (MPPG) has been found to have a positive influence on TC levels and other clinical-chemical values in some selected populations. |
Mendeley readers
The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 13 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 3 | 23% |
| Researcher | 3 | 23% |
| Student > Ph. D. Student | 2 | 15% |
| Student > Bachelor | 2 | 15% |
| Student > Master | 2 | 15% |
| Other | 0 | 0% |
| Unknown | 1 | 8% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 54% |
| Nursing and Health Professions | 2 | 15% |
| Agricultural and Biological Sciences | 1 | 8% |
| Sports and Recreations | 1 | 8% |
| Earth and Planetary Sciences | 1 | 8% |
| Other | 0 | 0% |
| Unknown | 1 | 8% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 August 2019.
All research outputs
#7,453,827
of 22,787,797 outputs
Outputs from European Journal of Clinical Pharmacology
#827
of 2,557 outputs
Outputs of similar age
#12,912
of 39,613 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#3
of 10 outputs
Altmetric has tracked 22,787,797 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,557 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 39,613 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.